Angiosarcoma of vagina successfully treated with interleukin-2 therapy and chemotherapy: A case report

Journal of Obstetrics and Gynaecology Research

Volumn 27, Issue 4, 2001, Pages 231-235

  Morimura, Y ^a   Hashimoto, T ^a   Soeda, S ^a   Fujimori, K ^a   Yamada, H ^a   Yanagida, K ^a   Sato, A ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiosarcoma; Interleukin 2 therapy; Vagina

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; SEROTONIN ANTAGONIST; VINCRISTINE;

ADENOCARCINOMA; ADULT; ANGIOSARCOMA; ARTICLE; BIOPSY TECHNIQUE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHILL; DISEASE CLASSIFICATION; DRUG FEVER; EDEMA; FATIGUE; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; PELVIS; PHYSICAL EXAMINATION; RADICAL HYSTERECTOMY; TUMOR REGRESSION; UTERINE CERVIX CARCINOMA; VAGINA BLEEDING; VAGINA TUMOR; VOMITING;

EID: 0034754115     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2001.tb01257.x     Document Type: Article

References (19)

1. Angiosarcoma following therapeutic irradiation
2. Angiosarcoma of the vagina. A reappraisal of the radiation treatment of angiosarcomas of the female genital tract
3. Vaginal and bladder angiosarcoma after therapeutic irradiation
4. Postirradiation angiosarcoma of the vaginal vault
5. Angiosarcoma of the vagina. A light and electronmicroscopy study
6. Vaginal epithelioid angiosarcoma
7. Morphological and clinical aspects of malignant vascular tumor of the uterus
8. Malignant hemangio-endothelioma of the uterus
9. Angiosarcoma of the uterus and ovary
10. Primary angiosarcoma of the ovary. A case report and review of the literature
11. Cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas
12. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas. A randomized study of the European organization for research and treatment of cancer soft tissue and bone sarcoma group
13. Interleukin-2 augments natural killer cell activity
14. Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancer
15. Successful immunotherapy for malignant hemangioendothelioma using recombinant interleukin-2
16. A case of malignant hemangioendothelioma showing response to interleukin-2 therapy
17. Malignant hemangioendothelioma
18. Interleukin-2 immunotherapy in children